Purchase Order 75N91019P00142
Award Date 4/10/19
Potential Completion Date 4/9/20
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02115, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to the University of California, Los Angeles for $21,139.00 on September 6, 2019. The order procures germline DNA samples and data from renal cell carcinoma patients for use in the National Cancer Institute's Renal Cell Carcinoma Genome-Wide Association Study. Work is performed in Los Angeles, California. The purchase order carries firm fixed-price pricing with an ultimate completion date of December 5, 2020.</p>
- <p>The National Cancer Institute awarded a purchase order to Mayo Clinic Jacksonville for $36,000 to obtain DNA samples and patient data for 1,100 renal cell carcinoma cases for inclusion in a genome-wide association study. Award date was September 13, 2018, with ultimate completion on March 12, 2020. The order was issued as firm fixed-price. Place of performance is Bethesda, Maryland. A no-cost extension was exercised during performance.</p>
- The National Cancer Institute awarded a purchase order to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. for $22,380.00 on February 19, 2019, with final completion on February 24, 2020. Work is performed in Tampa, Florida. The purchase order procures germline DNA samples and data from renal cell carcinoma patients to support the National Cancer Institute's Renal Cell Carcinoma Genome-Wide Association Study under the Department of Health and Human Services, National Institutes...
- <p>The National Cancer Institute awarded a purchase order to Health Research, Inc. (Roswell Park Division) valued at $16,380.00 on June 4, 2019, for germline DNA samples and data from renal cell carcinoma patients to support the NCI's Renal Cell Carcinoma Genome-Wide Association Study. Work is performed in Buffalo, New York. The order carries a firm fixed price structure and a completion date of December 3, 2020.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Centre International de Recherche sur le Cancer (IARC) for $22,124.00 on April 23, 2020, for germline DNA samples and data from renal cell carcinoma patients. Performance occurs in France with an ultimate completion date of April 30, 2021. The order is firm fixed price with no set-aside applied.</p>
- The National Cancer Institute awarded a purchase order to Brigham & Women's Hospital Inc. valued at $19,176.00 on February 19, 2020, to select and aliquot plasma samples from 39 cases and 39 matched controls, and separately from 32 cases and 32 matched controls. Performance occurs at the hospital's Department of Faulkner Pathology in Boston, Massachusetts. The order carries firm fixed-price pricing with an ultimate completion date of February 23, 2021. This purchase order was issued to...
- The National Cancer Institute awarded a purchase order to ECOG-ACRIN Medical Research Foundation, Inc. for digital transfer of clinical data and histological slide images, valued at $21,660.69, with an award date of June 15, 2026. Performance is located in Bethesda, Maryland. The order requires application of molecular prediction models to digitized histopathology slides from 1,154 clear cell kidney cancer patients, delivery of path-omic analysis and clinical correlation of the entire patient...
- <p>The National Cancer Institute issued a purchase order to The Broad Institute, Inc. for $13,480.01 on January 24, 2019, for custom lab work on a genomics platform. Work is performed in Cambridge, Massachusetts. The order is firm fixed-price with an ultimate completion date of July 25, 2019. No set-aside was used.</p>
- The National Cancer Institute awarded a purchase order to Brigham & Women's Hospital Inc., Department of Faulkner Pathology, for $10,829.00 on June 3, 2013, with final completion on June 2, 2014. The order is firm fixed price with no set-aside. Performance occurs in Boston, Massachusetts. The work involves aliquotting plasma samples from the Health Professionals Follow-Up Study and Nurses' Health Study to support a pooled investigation of adiponectin and multiple myeloma in the NCI Cohort...
- <p>The National Cancer Institute awarded a purchase order to The Children's Hospital Corporation (doing business as Boston Children's Hospital) valued at $14,964.00 on September 17, 2018, with a firm fixed price structure and ultimate completion date of October 1, 2019. Place of performance is Bethesda, Maryland. The order carries no set-aside designation.</p>